Please use a minimum of three unique search words
Our search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Cialis ® (tadalafil)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
Cialis (tadalafil): Effect of skipping dose
Clinical trials of tadalafil for the once daily treatment of ED and/or signs and symptoms of BPH did not study the effect of skipping doses.
Effect of skipping dose(s)
Tadalafil dosed once daily has been studied in clinical trials for the treatment of erectile
dysfunction (ED), the signs and symptoms of benign prostatic hyperplasia (BPH), and both ED and signs and symptoms of BPH. Once daily dosing allows the achievement of steady state plasma concentration and clinical efficacy was assessed following daily dosing (Cialis SmPC).
The impact of a missed day of therapy has not been studied, but impact on efficacy is likely to vary by patient. Some patients may notice reduced efficacy from missing a single dose, while others may not (Data on file).
REFERENCES
CIALIS EU Summary of Product Characteristics [SmPC], Utrecht, The Netherlands: Eli Lilly Nederland B.V.
Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: 11 November 2019
Contact Lilly
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com
Available Mon - Fri, 10am - 4pm, excluding Bank Holidays